Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RETIMAGER

Financiado

REAL TIME MOLECULAR IMAGER WITH UNSURPASSED RESOLUTION

Over the last decades, Positron Emission Tomography (PET) has been firmly established as the predominant molecular imaging technique due to its unmatched sensitivity and capability to address many different metabolic processes. Ho... ver más

28/02/2027

UC3M

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

UNIVERSIDAD CARLOS III DE MADRID No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 1332

Ver 6 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-12-12

HORIZON-EIC-2022-PATHFINDEROPEN-01-01: EIC Pathfinder Open 2022 Scope:You should apply to this call if you are looking for support from EIC Pathfinder Open to reali...

I+D

Cerrada hace 2 años

0% 100%

6 Participantes

UC3M

855.20K€ | Lider

INSERM

590.45K€ | Participante

FZJ

635.79K€ | Participante

UCM

499.64K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EQC2021-007636-P Sistema de imagen preclínica basado en Tomografía de Emisión... 974K€ Cerrado

PTQ2021-012117 Algoritmo de reconstrucción en modo lista con tiempo de vuel... 100K€ Cerrado

COMBIOSCOPY Computational Biophotonics for Endoscopic Cancer Diagnosis a... 1M€ Cerrado

DPI2008-06691 TECNICAS PARA LA FUSION DE IMAGENES MR Y PET PARA LA LOCALIZ... 47K€ Cerrado

IXSI3D Translating Hybrid Imaging for Interventions Intra operati... 2M€ Cerrado

MONOBREAST Low-dose breast CT with monochromatic x-ray sources 150K€ Cerrado

Duración del proyecto: 50 meses Fecha Inicio: 2022-12-12
Fecha Fin: 2027-02-28

Líder del proyecto

UNIVERSIDAD CARLOS III DE MADRID No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 1332

Presupuesto del proyecto 3M€

Descripción del proyecto Over the last decades, Positron Emission Tomography (PET) has been firmly established as the predominant molecular imaging technique due to its unmatched sensitivity and capability to address many different metabolic processes. However, there is huge room for improvement, as current clinical PET scanners are limited to spatial resolutions higher than 2.5 mm and temporal resolutions longer than 5 seconds. This hampers applications of PET for preclinical research and clinical diagnosis in small tissues or lesions and precludes real-time reconstruction of metabolic images. RETIMAGER is a proposal for a molecular imaging system with a ten-fold spatial and temporal improvement on the reconstructed image with respect to current PET devices. This will not only boost the quantitative performance, but it will enable new applications in cardiology, vascular oncology, oncology, neurology, and other areas. We will achieve this milestone by developing smart radiation detectors with non-conventional geometries that combine the advantages of both pixelated and monolithic detectors, the two dominant and seemingly incompatible technologies employed in PET scanners. Our new scanner will provide 0.25 mm pixel resolvability with time frames as short as 0.01 sec. By aggregating these blocks in a unique gantry self-adapting to the geometry of the field-of-view, RETIMAGER will achieve an unprecedented increase in sensitivity and in in vivo real-time imaging with submillimeter resolution. We will pair it with high-throughput data processing and AI tools to assess with a single tracer both perfusion and metabolism in preclinical and clinical models. In the long run, RETIMAGER’s faster, lower dose, and less invasive molecular imaging technology will become a game-changer for understanding disease processes by unveiling new accurate image-based quantitative biomarkers, taking scientific and healthcare stakeholders a step closer to personalized precision medicine.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores